Placebo Cediranib

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Metastatic Colorectal CancerRecurrent Glioblastoma

Phase 1

A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX

CompletedNCT00494221

AstraZenecaMetastatic Colorectal Cancer

Start: 2007-06-30End: 2012-08-31Updated: 2014-03-27

Phase 3

Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma

CompletedNCT00777153

AstraZenecaRecurrent Glioblastoma

Start: 2008-10-31End: 2016-09-30Updated: 2016-12-28